Virpax Pharmaceuticals, Inc. (VRPX) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 | Q3'20 | Q2'20 | Q1'20 |
|---|
| Total Current Assets | 1.56M | 304.16K | 2.59M | 3.13M | 9.63M | 13.04M | 15.95M | 18.49M | 19.67M | 23.64M | 29.4M | 34.75M | 39.57M | 43.27M | 11.39M | 13.22M | 73.07K | 274.56K | 825.15K | 41.54K |
| Cash & Short-Term Investments | 1.51M | 17.23K | 1.87M | 1.87M | 9.14M | 12.15M | 14.8M | 16.99M | 19M | 20.56M | 26.06M | 30.8M | 36.84M | 41.71M | 10.47M | 12.26M | 54.8K | 256.5K | 416.91K | 41.54K |
| Cash Only | 1.51M | 17.23K | 1.87M | 1.87M | 9.14M | 12.15M | 14.8M | 16.99M | 19M | 20.56M | 26.06M | 30.8M | 36.84M | 41.71M | 10.47M | 12.26M | 54.8K | 256.5K | 416.91K | -41.54K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 83.07K |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 37.91K | 273K | 128.12K | 505.9K | 283.37K | 448.43K | 424.83K | 543.69K | 496.27K | 2.59M | 2.55M | 2.88M | 2.57M | 1.1M | 5.73K | 3.05K | 535 | 3.64K | 382.5K | 0 |
| Total Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 392.34K | 176.39K | 73K | -41.54K |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 392.34K | 176.39K | 73K | -41.54K |
| Total Assets | 1.56M | 304.16K | 2.59M | 3.13M | 9.63M | 13.04M | 15.95M | 18.49M | 19.67M | 23.64M | 29.4M | 34.75M | 39.57M | 43.27M | 11.39M | 13.22M | 465.41K | 450.95K | 898.15K | 0 |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -83.84% | -97.67% | -83.76% | -83.07% | -51.06% | -44.84% | -45.75% | -46.78% | -50.28% | -45.38% | 158.19% | 162.84% | 8402.78% | 9495.93% | 1167.9% | - | 896.18% | - | - | - |
| Total Current Liabilities | 2.47M | 2.36M | 5.39M | 4.34M | 7.69M | 6.53M | 3.65M | 3.29M | 3.09M | 4.21M | 2.48M | 2.19M | 2.09M | 1.81M | 2.83M | 2.64M | 3.66M | 3.27M | 3.54M | 0 |
| Accounts Payable | 0 | 0 | 75.4K | 13.28K | 18.46K | 33.19K | 76.06K | 45.25K | 37.64K | 14.32K | 0 | 10.4K | 19.84K | 572 | 10K | 4.66K | 22.11K | 6.77K | 17.82K | 0 |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 50.51K | 50.51K | 543.99K | 535.54K | 1.46M | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -64.2K | -163.78K | -22.11K | -6.77K | 0 | 0 |
| Other Current Liabilities | 0 | 2.26M | 2.5M | 2.5M | 6M | 5M | 2M | 2M | 2M | 0 | 8K | 0 | 0 | 10K | 1.7M | 1.31M | 1.03M | 11.37K | 0 | 0 |
| Current Ratio | 0.63x | 0.13x | 0.48x | 0.72x | 1.25x | 2.00x | 4.37x | 5.61x | 6.36x | 5.62x | 11.84x | 15.89x | 18.96x | 23.88x | 4.02x | 5.01x | 0.02x | 0.08x | 0.23x | - |
| Quick Ratio | 0.63x | 0.13x | 0.48x | 0.72x | 1.25x | 2.00x | 4.37x | 5.61x | 6.36x | 5.62x | 11.84x | 15.89x | 18.96x | 23.88x | 4.02x | 5.01x | 0.02x | 0.08x | 0.23x | - |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.09M | 4.21M | 2.48M | 0 | 0 | 0 | 1.02M | 1.02M | 1.02M | 1.03M | 42.7K | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.02M | 1.02M | 1.02M | 1.03M | 42.7K | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 2.47M | 2.36M | 5.39M | 4.34M | 7.69M | 6.53M | 3.65M | 3.29M | 3.09M | 4.21M | 2.48M | 2.19M | 2.09M | 1.81M | 3.85M | 3.66M | 4.68M | 4.3M | 3.58M | 0 |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.07M | 1.07M | 1.57M | 1.57M | 1.51M | 0 |
| Net Debt | -1.51M | -17.23K | -1.87M | -1.87M | -9.14M | -12.15M | -14.8M | -16.99M | -19M | -20.56M | -26.06M | -30.8M | -36.84M | -41.71M | -9.39M | -11.19M | 1.51M | 1.31M | 1.09M | 41.54K |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.14x | 0.11x | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | -20.63x | -312.66x | - | -45.46x | - | - | - | - | - | - | -388.67x | - | -110.30x | -67.82x | -76.50x | -37.46x | -36.37x | -28.35x | -15.16x |
| Total Equity | -913.76K | -2.05M | -2.79M | -1.21M | 1.93M | 6.51M | 12.3M | 15.2M | 16.58M | 19.43M | 26.92M | 32.56M | 37.48M | 41.46M | 7.54M | 9.56M | -4.22M | -3.85M | -2.68M | -2.73M |
| Equity Growth % | -147.24% | -131.54% | -122.71% | -107.98% | -88.33% | -66.51% | -54.29% | -53.32% | -55.77% | -53.14% | 257.22% | 240.66% | 989.09% | 1177.91% | 380.76% | 449.81% | -54.31% | - | - | -129.08% |
| Book Value per Share | -0.21 | -0.44 | -1.41 | -1.04 | 1.65 | 5.55 | 10.50 | 12.97 | 14.15 | 1.66 | 2.30 | 2.78 | 5.61 | 6.90 | 1.52 | 2.42 | -0.94 | -0.85 | -0.54 | -0.55 |
| Total Shareholders' Equity | -913.76K | -2.05M | -2.79M | -1.21M | 1.93M | 6.51M | 12.3M | 15.2M | 16.58M | 19.43M | 26.92M | 32.56M | 37.48M | 41.46M | 7.54M | 9.56M | -4.22M | -3.85M | -2.68M | -2.73M |
| Common Stock | 149 | 49 | 28 | 12 | 12 | 117 | 117 | 117 | 117 | 117 | 117 | 117 | 117 | 117 | 50 | 49 | 31 | 31 | 155 | 0 |
| Retained Earnings | -71.61M | -68.22M | -66.21M | -62.76M | -59.54M | -54.98M | -48.99M | -45.88M | -44.35M | -41.37M | -33.73M | -27.84M | -22.7M | -18.59M | -15.37M | -13.03M | -10.65M | -9.94M | -8.23M | 0 |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.73M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |